Studying cancer and pre-cancer in Latin America
New research is focussing on understanding the genetic causes of acral melanoma - an understudied disease that is the most common type of melanoma in Mexico.
COSMIC: CASE STUDY
COSMIC is an online catalogue of somatic mutations in cancer, a gold standard data resource of global impact in the field of cancer genomics. The database has utility for basic research into the mechanisms of cancer but is also relevant for pharmaceutical R&D activities in oncology as well as the development of products and services in cancer diagnosis and patient stratification.
Why do some animals catch cancer?
Unravelling the genomics of infectious cancer
One childhood cancer, one thousand children: landmark genomic study delivers first discoveries
Tumours from 1000 children with kidney cancer have been sequenced, thanks to the Little Princess Trust and researchers at the Wellcome Sanger Institute. The Little Princess Trust ‘Knowledge Bank’ is the largest comprehensive genomics resource for any childhood solid tumour, and is already being used for research to understand childhood cancers.
Mosaic’s becoming
The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.
Searching for the roots of childhood cancer
Meet Thomas Oliver, trainee pathologist and PhD student, working on the origins of childhood cancers.
LiFTS: Li Fraumeni over Time Study – tracking changes in LFS
March 20th is Li Fraumeni Syndrome (LFS) Awareness Day. People will be on social media, wearing blue, #WearBlueForLFS, to raise awareness of this little-known cancer syndrome
Spinning out the science
Much of our research has the potential to positively impact people's lives around the world. And who better to deliver this than the scientists themselves?
Hunting for the unknown causes of cancer
Patient advocates share their involvement in the mutographs research project, their experiences of cancer, and their journey around the globe.
